Connect with us

FINANCE

SpaceX Stock Reclaims IPO Price After Classic Post-Listing Digestion

SpaceX stock SPCX finished Monday at $138.74 above its IPO price after the first lockup and retail net selling, echoing earlier mega-IPO cycles.

Published

on

SpaceX stock closed Monday at $138.74, reclaiming its $135 IPO price for the first time since July 15 and finishing up 4.23% on the day. The move came after the first major lockup tranche hit the market and after retail investors turned net sellers for the first time since the June listing.

Shares traded as high as $139.26 and as low as $130.17, with volume near 170 million. The reclaim arrives after a sharp post-earnings slide that took SPCX to a low near $104.83 earlier this month.

That path from listing premium to trough and back above the offer price compressed into roughly eight weeks. Few mega-cap debuts have packed a full distribution-and-reclaim cycle into so short a window, which is why Monday’s close drew such close attention on the tape.

The Numbers Behind Monday’s Close

According to SpaceX’s own investor page, the stock closed Monday at $138.74 after opening at $134.95. That put the market capitalization near $1.83 trillion at the close.

Vanda Research data, cited across market reports and confirmed in posts from Walter Bloomberg’s @DeItaone account, showed retail investors sold a net $4.5 million of SPCX on Friday. It was the first net retail selling day since the June 12 IPO. Earlier in the post-earnings week retail had bought aggressively, including a net $22.7 million in one opening hour.

  • IPO price: $135 on June 12, 2026
  • Intraday peak: $225.64 on June 16
  • Recent trough: $104.83 area in early August
  • Monday range: $130.17-$139.26, close $138.74

The first unlock of roughly 911.5 million shares became eligible on August 6. That block represented about 7% of shares outstanding and more than the original IPO float of roughly 639 million shares. Trading volume across the unlock window absorbed a large portion of the eligible supply without a collapse, and the stock still managed a weekly gain of more than 20% from the July 31 close near $108.

Put another way, the eligible block alone exceeded the entire IPO float, yet the weekly tape still advanced. Volume near 170 million on Monday showed that liquidity had thickened enough to clear size without forcing another leg lower through the IPO level.

Reference Level Price Context
IPO offer $135 June 12 listing price
June peak $225.64 Intraday high four days after listing
August trough $104.83 area Post-earnings low
July 31 close near $108 Base before unlock-week rebound
Monday close $138.74 First reclaim of IPO price since July 15

Why the Reclaim Landed Now

Two catalysts arrived in the same window. First came the company’s debut quarterly results as a public company. Second came the staggered lockup calendar that the June IPO prospectus lock-up terms had laid out months earlier.

SpaceX reported Q2 revenue of $7.8 billion, up 92% from $4.1 billion a year earlier and ahead of the roughly $6.9 billion consensus. Net loss narrowed to $541 million from $1.0 billion. Adjusted EBITDA rose to $3.5 billion. Cash, cash equivalents and marketable securities stood near $100 billion after the IPO proceeds.

The market initially sold the print hard because capital expenditures jumped to $18.37 billion, of which $15.83 billion went to AI infrastructure. Connectivity (Starlink) remained the profit engine. AI turned a smaller operating loss than feared and posted positive segment adjusted EBITDA. The same week SpaceX and Tesla detailed the Terafab semiconductor complex in Grimes County, Texas, with potential multi-phase investment that could reach well over $100 billion.

That combination of beat-and-raise operational data plus a clear AI build-out narrative gave institutions a reason to bid into the unlock supply. The first net retail selling day therefore landed as the stock was already bouncing hard off its lows.

Timing mattered as much as the print itself. By the time the August 6 tranche became eligible, the earnings detail and the Terafab outline were already in the market. Buyers who had waited for both a larger free float and cleaner public numbers could act in the same session as early holders who finally had a chance to sell.

Three Segments Tell Different Stories

The earnings release broke results into Space, Connectivity and AI. The numbers show why the market can hold two views at once.

Segment Q2 2026 Revenue YoY Change Op. Income/(Loss) Capex
Space $962 million +29% ($542 million) $1.17 billion
Connectivity $4.29 billion +66% $1.66 billion $1.37 billion
AI $2.56 billion +247% ($1.26 billion) $15.83 billion
Total $7.81 billion +92% ($143 million) $18.37 billion

Starlink ended the quarter with 12.0 million subscribers, double the year-ago figure, and ARPU held at $66. Enterprise and government revenue inside Connectivity grew even faster. The company booked more than $6 billion in multi-year Starshield contracts and closed $14.1 billion of cloud-services agreements. CFO Bret Johnsen said AI compute deployments are delivering paybacks of less than one year and that the firm is on a path toward $100 billion in annualized recurring revenue by year-end, including contributions from the pending Cursor acquisition.

Those figures explain both the long-term conviction on Wall Street and the short-term cash-flow anxiety that hit the stock after the print.

Connectivity carried the profit load while AI absorbed nearly all of the capex spike. Space remained a smaller revenue line with its own operating loss. The split lets bulls stress subscriber growth, contract backlog, and sub-one-year AI paybacks, while bears stress the absolute scale of infrastructure spending against still-negative total operating income.

  • Connectivity: $1.66 billion operating income on $4.29 billion revenue, the clear cash engine
  • AI: $2.56 billion revenue and a $1.26 billion operating loss beside $15.83 billion of segment capex
  • Space: $962 million revenue and a $542 million operating loss on more modest $1.17 billion capex

The Same Script Played Twice Before

Traders watching the tape immediately reached for two earlier examples. Facebook priced its 2012 IPO at $38, briefly traded higher, then spent months grinding toward $17 as early holders exited and the mobile story was still unproven. Palantir listed in 2020 amid heavy retail enthusiasm, ran hard, then bled toward single digits before the multi-year re-rating began.

In both cases the sequence ran the same way: retail-fueled IPO hype, institutional distribution into that demand, a period of boring accumulation once the float expanded, then a breakout once the growth story reasserted itself. Posts circulating on X this week mapped SPCX onto exactly those five phases and noted that Monday’s reclaim of the IPO price is the classic “second chance” window.

SpaceX is a perfect example of the stock market always giving you a second chance… Back to its $135 IPO price.

That observation from account @cmsinvests, which drew hundreds of likes, captures the crowd mood. Other high-engagement threads warned against chasing the bounce and instead watched lower levels near $85 as potential accumulation zones, treating the current reclaim as phase-three chop rather than the start of the next leg.

The parallel is imperfect. SpaceX already generates billions in cash from Starlink and holds a massive cash pile. Yet the human pattern of retail enthusiasm meeting sudden float expansion looks familiar.

Mapping the shared phases onto the SPCX tape makes the comparison concrete without forcing a perfect match on fundamentals.

  1. Retail-fueled debut: IPO at $135, peak at $225.64 within days
  2. Distribution into strength: heavy early volume and the long slide toward the $104.83 area
  3. Float expansion: August 6 unlock of roughly 911.5 million shares
  4. First retail net selling: Friday’s net $4.5 million outflow, the first since June 12
  5. IPO-price reclaim: Monday’s $138.74 close, the “second chance” window named on X

Who Absorbed the Shares

Early investors and some retail holders used the unlock window. One high-profile example was Atlanta Falcons safety Jessie Bates III, who told CNBC he planned to sell his entire stake, originally purchased for about $150,000 at a far lower private valuation. Musk’s own holdings remain locked until June 2027.

On the other side of the tape sat institutions that had waited for clearer post-IPO financials and a larger free float. Argus Research upgraded the stock from Hold to Buy with a $160 target, citing rapid payback on capital spending. Morgan Stanley has kept a $300 base-case target. Consensus across roughly 40 analysts sits near $227-$231, with the high end still marked by the Raymond James $800 price target. The low end of the range sits near $115.

The ability of SPCX to finish above the IPO price while hundreds of millions of newly eligible shares changed hands suggests the institutional bid is deeper than the first retail net-sell day implies. That same dynamic appeared earlier when Nasdaq-100 inclusion buying force was expected to create mechanical demand.

The analyst range itself frames the debate. A floor near $115 still sits below the IPO price, while the $160 Argus target and the $300 Morgan Stanley base case sit well above Monday’s close. Consensus near $227-$231 implies the Street still prices a path back through the June peak zone over time, even after the first unlock cleared.

More Float Still Ahead

August 6 was only the first and largest single tranche. The staggered schedule continues.

  1. August 20, 2026: roughly 319 million additional shares become eligible
  2. September 2026: approximately 700 million more
  3. October 2026: a similar-sized block
  4. Through mid-2027: the bulk of the remaining pre-IPO float, totaling more than 12 billion shares across the full schedule

Mizuho and JPMorgan both noted that eligibility does not equal automatic selling. Pre-positioning and tax or diversification motives vary by holder. Still, each new tranche tests whether demand can keep absorbing supply the way it did last week. The earlier episode of earlier thin-float and lockup pressures already showed how sensitive the stock can be when free float is tight.

Analysts who remain constructive point to the $100 billion ARR target, the Cursor deal, Starship progress, and the Nvidia partnership on orbital compute as the fundamental offsets. Those who stay cautious focus on the absolute size of AI capital spending and the possibility that later unlocks arrive into a weaker tape.

August 20’s roughly 319 million shares are smaller than the first tranche, yet September’s approximately 700 million block again approaches the scale of the IPO float. Stacked against a full schedule above 12 billion shares through mid-2027, Monday’s absorption reads as a first stress test rather than the final one.

Starlink Cash Flow Funds the AI Build

The segment mix explains how the company can post a narrowed net loss and rising adjusted EBITDA while still spending $18.37 billion in a single quarter. Connectivity’s $1.66 billion operating income and steady $66 ARPU give the balance sheet a recurring cash engine that pure AI stories often lack at this stage.

AI revenue already reached $2.56 billion, up 247% year over year, and the segment posted positive adjusted EBITDA even as it ran a $1.26 billion operating loss. CFO Bret Johnsen’s comment on paybacks of less than one year is the bridge bulls use between that loss and the $15.83 billion of AI capex.

Cash near $100 billion after IPO proceeds adds another buffer. It does not remove the spending debate, but it does change the urgency. The same pile that funded the public debut now stands behind the Terafab outline and the path toward $100 billion in annualized recurring revenue, including the pending Cursor piece.

In short, Starlink and the related contract backlog are what let the market treat the AI build-out as a growth allocation rather than an existential cash drain. That framing is what allowed institutions to bid through the first unlock instead of stepping aside.

Monday Close Leaves Two Paths Open

Above $135, the tape has restored the listing reference point that broke during the post-earnings slide. Below the June $225.64 peak, the stock still carries a drawdown of roughly 38%, so the reclaim is a base candidate rather than a full recovery.

One path treats Monday as the start of durable accumulation: institutions keep absorbing each staggered tranche, retail net selling stays modest, and the ARR and payback narrative offsets the capex headlines. The other path treats the reclaim as phase-three chop, with later unlocks in September and October arriving into softer demand and retesting levels nearer the August trough or the $85 zone some threads still watch.

Nothing in Monday’s close chooses between those paths. It only shows that the largest single unlock of the cycle cleared while the stock finished above the IPO price and retail, for one session, stood on the sell side.

What the Tape Has Already Shown

In eight weeks public life SPCX has already run the full classic mega-IPO cycle once: debut pop, parabolic high, 50% drawdown from peak, first big unlock, first retail net selling, and a reclaim of the original IPO price. The stock now sits roughly 38% below its June high and a few percent above the listing price.

Whether that reclaim becomes a durable base or simply another pause before the next supply test will be decided by the next few unlock windows and by whether the AI and Starlink growth rates continue to outrun the spending curve. For now the market has demonstrated it can absorb the largest single unlock of the cycle without breaking the IPO level. That is the concrete fact Monday’s close delivered.

The next tranches will repeat the same question under different conditions. Demand that worked against 911.5 million newly eligible shares must prove it can do so again when the calendar brings the August 20, September, and October blocks. Until then, Monday’s $138.74 close remains the clearest evidence yet that the institutional bid can meet size at the IPO line.

As the founder of Thunder Tiger Europe Media, Dr. Elias Thornwood brings over 25 years of experience in international journalism, having reported from conflict zones in the Middle East, Asia, and Africa for outlets like BBC World and Reuters. With a PhD in International Relations from Oxford University, his expertise lies in geopolitical analysis and global diplomacy. Elias has authored two bestselling books on European foreign policy and received the Pulitzer Prize for International Reporting in 2015, establishing his authoritativeness in the field. Committed to trustworthiness, he enforces rigorous fact-checking protocols at Thunder Tiger, ensuring unbiased, evidence-based coverage of worldwide news to empower informed global audiences.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending